Clinical trial
Study of BHV-4157 in Alzheimer's Disease
NCT03605667
Study timeline
Study start (actual)2018-07-31Date precision: day
Registry last updated2023-12-06
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Alzheimer Diseaseunresolved
Interventions
troriluzoleDRUG
Sponsors & collaborators
Biohaven Pharmaceuticals, Inc.lead sponsor
Alzheimer's Disease Cooperative Study (ADCS)collaborator
Mapped research locations
ChicagoIllinois, United States2PhoenixArizona, United States2New YorkNew York, United States1Los AngelesCalifornia, United States1BaltimoreMaryland, United States1MiamiFlorida, United States1San AntonioTexas, United States1NashvilleTennessee, United States1SeattleWashington, United States1PittsburghPennsylvania, United States1ColumbusOhio, United States1TampaFlorida, United States1
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT03605667 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.